{"id":46051,"date":"2025-11-07T12:52:28","date_gmt":"2025-11-07T04:52:28","guid":{"rendered":"https:\/\/flcube.com\/?p=46051"},"modified":"2025-11-07T12:52:29","modified_gmt":"2025-11-07T04:52:29","slug":"judge-rejects-pfizers-attempt-to-block-novo-nordisks-10-bn-bid-for-metsera","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=46051","title":{"rendered":"Judge Rejects Pfizer\u2019s Attempt to Block Novo Nordisk\u2019s $10\u202fbn Bid for Metsera"},"content":{"rendered":"\n<p>Delaware Court of Chancery Judge <strong>Morgan Zurn<\/strong> denied <strong>Pfizer\u2019s<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/PFE:NYSE\">NYSE: PFE<\/a>) request for a temporary injunction that would have halted <strong>Novo Nordisk\u2019s<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/NVO:NYSE\">NYSE: NVO<\/a>) hostile takeover of <strong>Metsera<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/MTSR:NASDAQ\">NASDAQ: MTSR<\/a>). The ruling, issued Wednesday, concluded that Pfizer\u2019s objections \u201cdo not warrant a delay\u201d of the transaction.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-background-of-the-bidding-war\">Background of the Bidding War<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Timeline<\/th><th>Party<\/th><th>Offer Value (USD)<\/th><th>Structure<\/th><\/tr><\/thead><tbody><tr><td><strong>Sept\u202f2025<\/strong><\/td><td><strong>Pfizer<\/strong><\/td><td>$4.9\u202fbn (up to $7.3\u202fbn with earn\u2011outs)<\/td><td>Cash + contingent payments<\/td><\/tr><tr><td><strong>Oct\u202f2025<\/strong><\/td><td><strong>Novo Nordisk<\/strong><\/td><td>$6\u202fbn (up to $9\u202fbn)<\/td><td>Cash + non\u2011voting stock<\/td><\/tr><tr><td><strong>Early\u202fNov\u202f2025<\/strong><\/td><td><strong>Novo <\/strong><br><strong>Nordisk (re\u2011bid)<\/strong><\/td><td>$10\u202fbn (vs. Pfizer\u2019s revised $8.1\u202fbn)<\/td><td>Up\u2011front cash, non\u2011voting stock for Metsera shareholders<\/td><\/tr><tr><td><strong>Nov\u202f4\u202f2025<\/strong><\/td><td><strong>FTC Letter<\/strong><\/td><td>\u2014<\/td><td>Warns Novo\u2019s offer could breach the Hart\u2011Scott\u2011Rodino Act if pre\u2011merger filing is omitted<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>Pfizer initially announced a definitive agreement to acquire Metsera for <strong>$4.9\u202fbn<\/strong>, with potential earn\u2011outs that could lift the total to <strong>$7.3\u202fbn<\/strong>. Novo\u202fNordisk responded with a higher cash\u2011plus\u2011equity proposal, eventually raising its bid to <strong>$10\u202fbn<\/strong> to outpace Pfizer\u2019s revised <strong>$8.1\u202fbn<\/strong> offer.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-antitrust-amp-regulatory-scrutiny\">Antitrust &amp; Regulatory Scrutiny<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>FTC Involvement<\/strong> \u2013 In a letter dated Nov.\u202f4, <strong>Daniel Guarnera<\/strong>, director of the FTC\u2019s Bureau of Competition, warned that Novo\u2019s bid could violate the <strong>Hart\u2011Scott\u2011Rodino Pre\u2011Merger Notification Act<\/strong> unless a formal pre\u2011merger filing is made.<\/li>\n\n\n\n<li><strong>Deal Structure<\/strong> \u2013 Novo\u2019s bid is engineered to deliver most of the purchase price up\u2011front in cash, while granting Metsera investors <strong>non\u2011voting stock<\/strong>. This structure is intended to mitigate a protracted antitrust review.<\/li>\n\n\n\n<li><strong>Company Statements<\/strong> \u2013 Metsera dismissed Pfizer\u2019s antitrust concerns as \u201cnonsense.\u201d Novo called the objections \u201cabsurd\u201d and asserted that the transaction complies with U.S. antitrust law. Novo also said it is in ongoing dialogue with the FTC to resolve any outstanding issues.<\/li>\n<\/ul>\n\n\n\n<p>The FTC has indicated it will not take a position on the deal until its review is complete.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-impact\">Market Impact<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Pfizer<\/strong> \u2013 Shares slipped 1.3% in after\u2011hours trading following the court\u2019s decision, reflecting investor uncertainty about the company\u2019s ability to secure the target.<\/li>\n\n\n\n<li><strong>Novo\u202fNordisk<\/strong> \u2013 Stock rose 2.1% as the firm gained a clear path to close the acquisition, reinforcing its strategic push into the rare\u2011disease space where Metsera\u2019s pipeline sits.<\/li>\n\n\n\n<li><strong>Metsera<\/strong> \u2013 Shares rallied 3.5% on the news, benefitting from the higher\u2011priced bid and the clarified regulatory outlook.<\/li>\n<\/ul>\n\n\n\n<p>Analysts note that the outcome reinforces the growing trend of <strong>cash\u2011plus\u2011non\u2011voting\u2011stock<\/strong> structures in contested M&amp;A deals, especially where antitrust review timelines are expected to be lengthy.<\/p>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This release contains forward\u2011looking statements regarding the Pfizer\u2011Novo\u202fNordisk\u2011Metsera transaction and related regulatory matters. Actual results may differ due to risks and uncertainties described in the companies\u2019 filings with the SEC.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Delaware Court of Chancery Judge Morgan Zurn denied Pfizer\u2019s (NYSE: PFE) request for a temporary&#8230;<\/p>\n","protected":false},"author":1,"featured_media":46054,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1],"tags":[4364,4365,148,860,863,309],"class_list":["post-46051","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","tag-metsera","tag-nasdaq-mtsr","tag-novo-nordisk","tag-nyse-nvo","tag-nyse-pfe","tag-pfizer"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Judge Rejects Pfizer\u2019s Attempt to Block Novo Nordisk\u2019s $10\u202fbn Bid for Metsera - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Delaware Court of Chancery Judge Morgan Zurn denied Pfizer\u2019s (NYSE: PFE) request for a temporary injunction that would have halted Novo Nordisk\u2019s (NYSE: NVO) hostile takeover of Metsera (NASDAQ: MTSR). The ruling, issued Wednesday, concluded that Pfizer\u2019s objections \u201cdo not warrant a delay\u201d of the transaction.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=46051\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Judge Rejects Pfizer\u2019s Attempt to Block Novo Nordisk\u2019s $10\u202fbn Bid for Metsera\" \/>\n<meta property=\"og:description\" content=\"Delaware Court of Chancery Judge Morgan Zurn denied Pfizer\u2019s (NYSE: PFE) request for a temporary injunction that would have halted Novo Nordisk\u2019s (NYSE: NVO) hostile takeover of Metsera (NASDAQ: MTSR). The ruling, issued Wednesday, concluded that Pfizer\u2019s objections \u201cdo not warrant a delay\u201d of the transaction.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=46051\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-07T04:52:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-07T04:52:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0703.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46051#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46051\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Judge Rejects Pfizer\u2019s Attempt to Block Novo Nordisk\u2019s $10\u202fbn Bid for Metsera\",\"datePublished\":\"2025-11-07T04:52:28+00:00\",\"dateModified\":\"2025-11-07T04:52:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46051\"},\"wordCount\":467,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46051#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0703.webp\",\"keywords\":[\"Metsera\",\"NASDAQ: MTSR\",\"Novo Nordisk\",\"NYSE: NVO\",\"NYSE: PFE\",\"Pfizer\"],\"articleSection\":[\"Others\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=46051#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46051\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=46051\",\"name\":\"Judge Rejects Pfizer\u2019s Attempt to Block Novo Nordisk\u2019s $10\u202fbn Bid for Metsera - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46051#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46051#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0703.webp\",\"datePublished\":\"2025-11-07T04:52:28+00:00\",\"dateModified\":\"2025-11-07T04:52:29+00:00\",\"description\":\"Delaware Court of Chancery Judge Morgan Zurn denied Pfizer\u2019s (NYSE: PFE) request for a temporary injunction that would have halted Novo Nordisk\u2019s (NYSE: NVO) hostile takeover of Metsera (NASDAQ: MTSR). The ruling, issued Wednesday, concluded that Pfizer\u2019s objections \u201cdo not warrant a delay\u201d of the transaction.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46051#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=46051\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46051#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0703.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0703.webp\",\"width\":1080,\"height\":608,\"caption\":\"Judge Rejects Pfizer\u2019s Attempt to Block Novo Nordisk\u2019s $10\u202fbn Bid for Metsera\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46051#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Judge Rejects Pfizer\u2019s Attempt to Block Novo Nordisk\u2019s $10\u202fbn Bid for Metsera\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Judge Rejects Pfizer\u2019s Attempt to Block Novo Nordisk\u2019s $10\u202fbn Bid for Metsera - Insight, China&#039;s Pharmaceutical Industry","description":"Delaware Court of Chancery Judge Morgan Zurn denied Pfizer\u2019s (NYSE: PFE) request for a temporary injunction that would have halted Novo Nordisk\u2019s (NYSE: NVO) hostile takeover of Metsera (NASDAQ: MTSR). The ruling, issued Wednesday, concluded that Pfizer\u2019s objections \u201cdo not warrant a delay\u201d of the transaction.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=46051","og_locale":"en_US","og_type":"article","og_title":"Judge Rejects Pfizer\u2019s Attempt to Block Novo Nordisk\u2019s $10\u202fbn Bid for Metsera","og_description":"Delaware Court of Chancery Judge Morgan Zurn denied Pfizer\u2019s (NYSE: PFE) request for a temporary injunction that would have halted Novo Nordisk\u2019s (NYSE: NVO) hostile takeover of Metsera (NASDAQ: MTSR). The ruling, issued Wednesday, concluded that Pfizer\u2019s objections \u201cdo not warrant a delay\u201d of the transaction.","og_url":"https:\/\/flcube.com\/?p=46051","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-11-07T04:52:28+00:00","article_modified_time":"2025-11-07T04:52:29+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0703.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=46051#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=46051"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Judge Rejects Pfizer\u2019s Attempt to Block Novo Nordisk\u2019s $10\u202fbn Bid for Metsera","datePublished":"2025-11-07T04:52:28+00:00","dateModified":"2025-11-07T04:52:29+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=46051"},"wordCount":467,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=46051#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0703.webp","keywords":["Metsera","NASDAQ: MTSR","Novo Nordisk","NYSE: NVO","NYSE: PFE","Pfizer"],"articleSection":["Others"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=46051#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=46051","url":"https:\/\/flcube.com\/?p=46051","name":"Judge Rejects Pfizer\u2019s Attempt to Block Novo Nordisk\u2019s $10\u202fbn Bid for Metsera - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=46051#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=46051#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0703.webp","datePublished":"2025-11-07T04:52:28+00:00","dateModified":"2025-11-07T04:52:29+00:00","description":"Delaware Court of Chancery Judge Morgan Zurn denied Pfizer\u2019s (NYSE: PFE) request for a temporary injunction that would have halted Novo Nordisk\u2019s (NYSE: NVO) hostile takeover of Metsera (NASDAQ: MTSR). The ruling, issued Wednesday, concluded that Pfizer\u2019s objections \u201cdo not warrant a delay\u201d of the transaction.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=46051#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=46051"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=46051#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0703.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0703.webp","width":1080,"height":608,"caption":"Judge Rejects Pfizer\u2019s Attempt to Block Novo Nordisk\u2019s $10\u202fbn Bid for Metsera"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=46051#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Judge Rejects Pfizer\u2019s Attempt to Block Novo Nordisk\u2019s $10\u202fbn Bid for Metsera"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0703.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46051","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=46051"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46051\/revisions"}],"predecessor-version":[{"id":46055,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46051\/revisions\/46055"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/46054"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=46051"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=46051"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=46051"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}